Herve Nozach

Researcher at CEA, focuses on molecular engineering of monoclonal antibodies

[Olivier Schwartz Lab @Virus_Immunity]

How do antibodies cooperate?
Nice work by @MOUQUETHugo1 and coll.
Broad Sarbecovirus Neutralization by Combined Memory B-cell Antibodies to Ancestral SARS-CoV-2:
https://t.co/Jyr8ZKO3DY

[Bloom Lab @jbloom_lab]

In new study led by Caleb Carr & @khdcrawford, we measure how all mutation to Lassa virus glycoprotein complex (GPC) affect cell entry & antibody escape

Results show how prospective assessment of effects of mutations can inform design of countermeasures
https://t.co/M2LmbTbwKm

[Marc Gozlan @MarcGozlan]

Comment le SARS-CoV-2 peut évoluer en variant préoccupant chez un individu immunodéprimé. À lire sur 'Réalités Biomédicales' https://t.co/bV0TtThuh7

[Herve Nozach @NozachH]

@canardbruno Il y a quand même des résultats encourageants pour le sotrovimab qui a des efficacités remarquables en clinique

[Abdel Abdellaoui @dr_appie]

"We have incorporated all the reviewers' comments, which we believe has substantially improved our work"

[Herve Nozach @NozachH]

Deep Mutational Engineering of broadly-neutralizing and picomolar affinity nanobodies to accommodate SARS-CoV-1 & 2 antigenic polymorphism https://t.co/CYhspHbM8M